Reports
Publications
Presented papers
- Poster at 5th Global Conference on Neuroscience and Neurological Disorders, November 03-04, 2022| Berlin, Germany. Targeting CB2 receptors: potential investigational therapies for dementia due to Alzheimer’s disease by Gabriela Dumitrita Stanciu, B.I. Tamba;
- Poster at 6th Edition of International Conference on Neurology and Brain Disorders during October 24-26, 2022| Orlando, Florida, USA. Preclinical in vivo study on selective cannabinoid receptor type 2 and donepezil combined therapy in Alzheimer’s disease by Gabriela Dumitrita Stanciu, B.I. Tamba;
Published papers
- Review paper: Stanciu GD; Ababei DC; Rusu RN; Bild V; Tamba BI. Exploring the involvement of the amyloid precursor protein A673T mutation against amyloid pathology and Alzheimer’s disease in relation to therapeutic editing tools. Pharmaceutics. 2022 Jun; 14(6): 1270.
Courses
- From behavioral methods for assessing cognitive performance to neurodegeneration – relevant solutions for improving preclinical to clinical translation in Alzheimer’s disease research by Gabriela Dumitrita STANCIU at Advanced Research and Development Center for Experimental Medicine “Prof. Ostin C. Mungiu” – CEMEX, Iasi, Romania during the 18th edition of the International Congress for medical Students and Young Doctors – CONGRESSIS, 3rd-7th of May, 2023.
- Cognitive and behavioral assessment in dementia due to Alzheimer’s disease on laboratory animals by Gabriela Dumitrita STANCIU at Advanced Research and Development Center for Experimental Medicine “Prof. Ostin C. Mungiu” – CEMEX, Iasi, Romania during the 17th edition of the International Congress for medical Students and Young Doctors – CONGRESSIS, 11th- 15th of May 2022.